NCT07642362 Digital Support for Multiple Myeloma Quality of Life
| NCT ID | NCT07642362 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CareAcross |
| Condition | Multiple Myeloma |
| Study Type | INTERVENTIONAL |
| Enrollment | 108 participants |
| Start Date | 2025-02-27 |
| Primary Completion | 2028-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 108 participants in total. It began in 2025-02-27 with a primary completion date of 2028-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this prospective study is to investigate the quality of life of patients with multiple myeloma and the effectiveness of support provided through a personalized web-based platform. Specifically, the study will compare Patient-Reported Outcomes (PROs) and the associated improvement in side effects and quality of life achieved through appropriate personalized educational and supportive content.
Eligibility Criteria
Inclusion Criteria: * Adult patients with newly diagnosed or relapsed/refractory multiple myeloma * Patients that are able to use the digital platform/application Exclusion Criteria: * Patients that are not able to use the digital platform/application
Frequently Asked Questions
Who can join the NCT07642362 clinical trial?
This trial is open to participants of all sexes, studying Multiple Myeloma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07642362 currently recruiting?
Yes, NCT07642362 is actively recruiting participants. Visit ClinicalTrials.gov or contact CareAcross to inquire about joining.
Where is the NCT07642362 trial being conducted?
This trial is being conducted at Athens, Greece.
Who is sponsoring the NCT07642362 clinical trial?
NCT07642362 is sponsored by CareAcross. The trial plans to enroll 108 participants.